In terms of the types and mix of deals that closed, COVID-19 had sharply different effects on each sector and even segments within a sector. The...
2021 is shaping up to be another wild ride The pandemic ensured that 2020 was unlike any other year for MedTech companies. But, while this sector...
During 2020, the COVID-19 pandemic highlighted the critical importance of an operational global biopharma supply chain, but it also exposed its vulnerability to global shocks. Companies...
Healthcare can become more resilient, agile, and innovative by shifting to digitally enabled business models with data at the core. The COVID-19 pandemic, and not the...
The coronavirus pandemic has been the driving force shaping the biopharma and medtech sectors over the first half of 2020. And, while much of the fallout...
Copyright © 2023 Medical Buyer